California, USA, Aug.9 (NSS): Amgen has announced plans to open a new technology and innovation site in Hyderabad.
The site, known as Amgen India, will accelerate digital capabilities across the global organisation to further advance Amgen’s pipeline of medicines.
Amgen India will be located in HITEC City and can accommodate up to 3,000 people. It will be operational in Q4 2024.
“At a time when a quickly aging global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency —an incredibly exciting milestone for which we have been preparing for over a decade,” said David M Reese, M.D., executive vice president and chief technology officer at Amgen.
“Amgen has been a leader in biotechnology for over 40 years and establishing this new site in India, a country known for its world-class technology and life sciences talent, marks a significant step forward in our journey to deliver on our mission to serve patients.”
Amgen India will initially build and accelerate new technology solutions and digital capabilities at scale that will enhance efficiencies across the enterprise.
The site will offer roles that strengthen key areas of Amgen’s business, including AI, data science, life science and other additional global capabilities over time.
To lead Amgen’s expanded presence in India, Som Chattopadhyay has been appointed national executive for India.
Chief Minister Revanth Reddy said, “it is a great breakthrough and a matter of pride for us to have one of the world’s largest biotech firms choose Hyderabad for its first development facilities in Telangana.”
“Amgen’s new site in Hyderabad underscores the city’s position as a hub for innovation and technology,” he added.
Chief Minister Revanth Reddy and Industries Minister Sridhar Babu met Dr. David Reese and Som Chattopadhyay at Amgen’s R&D site in San Francisco.
